The observation that PCSK9 is involved in the pathophysiology of inflammation, heart disease, atherosclerosis, nephrotic syndrome, hepatic steatosis, infections, and cancer metastases might positively influence on the therapeutic approach to those diseases in the future. This evidence concerns the gene PCSK9 and nephrotic syndrome.